A prospective,multicenter, randomized, parallel-group,open-label study of aripiprazole in the management of patients with schizophrenia

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2009
INTERVENTION: Aripiprazole Standard control CONDITION: Schizophrenia PRIMARY OUTCOME: Preference of Medicine(POM) INCLUSION CRITERIA: With a diagnosis of schizophrenia and noticed as schizophrenia. Outpatients. Taking a certain antipsychotic four weeks long. A switch from current antipsychotic medicine was judged clinically reasonable.
Epistemonikos ID: 3d995ec1a00368cbbf0447b39cbdd113024c3034
First added on: Aug 22, 2024